World Journal of Surgery

, Volume 30, Issue 7, pp 1138–1146

The Landmark Surgical Trials of the National Surgical Adjuvant Breast and Bowel Project

  • D. Lawrence Wickerham
  • Joseph P. Costantino
  • Eleftherios P. Mamounas
  • Thomas B. Julian
Article

Abstract

In this paper we provide a summary of several of the completed and ongoing surgical trials of the National Surgical Adjuvant Breast and Bowel Project, one of the cancer cooperative trials groups supported by the US National Cancer Institute.

References

  1. 1.
    Fisher B, Montague E, Redmond C, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer: a first report of results from a prospective randomized clinical trial. Cancer 1977;39:2827–2939PubMedCrossRefGoogle Scholar
  2. 2.
    Fisher B, Jeong J, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002;347:567–575PubMedCrossRefGoogle Scholar
  3. 3.
    Moxley J, Allegra J, Durant J, et al. The treatment of primary breast cancer: management of local disease. National Institutes of Health Consensus Development Conference Statement. June 1979Google Scholar
  4. 4.
    Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985;312:665–673PubMedCrossRefGoogle Scholar
  5. 5.
    Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;320:822–828. Erratum in N Engl J Med 1994;330:1467PubMedCrossRefGoogle Scholar
  6. 6.
    Fisher B, Anderson S, Redmond C, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:22:1456–1461Google Scholar
  7. 7.
    Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233–1241PubMedCrossRefGoogle Scholar
  8. 8.
    Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227–1232PubMedCrossRefGoogle Scholar
  9. 9.
    Veronesi U, Saccozzi R, DelVecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981;305:6–11PubMedCrossRefGoogle Scholar
  10. 10.
    Wood W, Barringer T, Daly J, et al. Treatment of early-stage breast cancer. National Institutes of Health Consensus Development Conference Statement. June 1990Google Scholar
  11. 11.
    Fisher B, Land S, Mamounas E, et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 2001;28:400–418PubMedCrossRefGoogle Scholar
  12. 12.
    Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581–1586PubMedCrossRefGoogle Scholar
  13. 13.
    Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16:441–452PubMedGoogle Scholar
  14. 14.
    Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast and Powel Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 1999;86:429–438PubMedCrossRefGoogle Scholar
  15. 15.
    Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345–2350PubMedGoogle Scholar
  16. 16.
    Kim T, Agboola O, Lyman GH, et al. Lymphatic mapping and sentinel lymph node sampling in breast cancer: a meta-analysis. Proc Am Soc Clin Oncol 2002;21:139a (abstract)Google Scholar
  17. 17.
    Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335–339; Discussion 340PubMedCrossRefGoogle Scholar
  18. 18.
    Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med 1998;339:941–946PubMedCrossRefGoogle Scholar
  19. 19.
    McMasters KM, Tuttle TM. Carson DL, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560–2566PubMedGoogle Scholar
  20. 20.
    Tafra L, Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001;233:51–59PubMedCrossRefGoogle Scholar
  21. 21.
    Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864–1867PubMedCrossRefGoogle Scholar
  22. 22.
    Julian TB, Krag D, Brown A, et al. Preliminary technical results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer patients. San Antonio Breast Cancer Symp 2004 (Abstract 14)Google Scholar
  23. 23.
    Wapnir I, Anderson S, Tan-Chiu E, et al. Ipsilateral breast tumor recurrence (IBTR) and survival in NSABP node-positive breast cancer protocols. Proc Am Soc Clin Oncol 2000 (Abstract 315)Google Scholar
  24. 24.
    Halverson KJ, Perez CA, Kuske RR, et al. Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 1992;23:285–291PubMedGoogle Scholar
  25. 25.
    Borner M, Bacchi M, Goldhirsch A, et al. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research. J Clin Oncol 1994;12:2071–2077PubMedGoogle Scholar
  26. 26.
    Henderson IC, Berry G, Demetri C, et al. Improved disease-free survival (DFS) and overall survival (OS) from the addition of sequential paclitaxel (T) but not from the escalation of doxorubicin (A) dose level in the adjuvant chemotherapy of patients with node-positive primary breast cancer. Proc Am Soc Clin Oncol 1998; 17 (abstract)Google Scholar
  27. 27.
    Bear HD, Anderson S, Brown A, et al. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2003; 21:4165–4174PubMedCrossRefGoogle Scholar
  28. 28.
    Bear HD, Anderson S, Smith RE, et al. Sequential preoperative or postoperative docetaxel (added) to Preoperative doxorubicin plus cyclophosphamide for operable breast cancer. National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2006;24:2019–2027PubMedCrossRefGoogle Scholar
  29. 29.
    Mamounas EP, Bryant J, Lembersky B, et al. Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: Results from NSABP B-28. J Clin Oncol 2005;23:3686–3696PubMedCrossRefGoogle Scholar
  30. 30.
    Ciron ML, Berry DA, Cirrincione C, et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup trial C9741/Cancer and Leukemia Group B trial 9741. J Clin Oncol 2003;21:1431–1439CrossRefGoogle Scholar
  31. 31.
    Wolmark N, Wang J, Mamounas E, et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001;30:96–102PubMedGoogle Scholar
  32. 32.
    Paik S. Incorporating genomics into the cancer clinical trial process. Semin Oncol 2001;283:305–309PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2006

Authors and Affiliations

  • D. Lawrence Wickerham
    • 1
    • 4
    • 5
  • Joseph P. Costantino
    • 2
  • Eleftherios P. Mamounas
    • 3
  • Thomas B. Julian
    • 1
    • 4
  1. 1.National Surgical Adjuvant Breast and Bowel Project (NSABP)PittsburghUSA
  2. 2.NSABP Biostatistical CenterOne sterling PlazaPittsburghUSA
  3. 3.Aultman HospitalCantonUSA
  4. 4.Allegheny General HospitalPittsburghUSA
  5. 5.NSABPPittsburghUSA

Personalised recommendations